GHK-Cu's mechanisms appear to involve antioxidant protection of neurons from oxidative damage, anti-inflammatory effects reducing microglial activation and neuroinflammation, modulation of gene expression patterns favoring neuroprotection, and potential effects on protein aggregation reducing pathological deposits
Common qualifying conditions include high blood pressure, type 2 diabetes, prediabetes, high cholesterol, obstructive sleep apnea, and cardiovascular disease
Vallee A, Lecarpentier Y, Vallee JN
G., Heroux, A., Smith, C
RRM1 (sc-11733, 1:1000), and RRM2 (sc-10846, 1:1000) from Santa Cruz